A turbo-charged fed rate cut provided fuel to a lot of names in our portfolio this week.

Here's an overview of the biggest weekly moves through close on Thursday, Sept. 19.

Mobileye (MBLY): +22%

Mobileye shares surged on news that the rumor of Intel divesting its stake was in fact that, a rumor. Mobileye also made waves when it announced it was de-emphasizing lidar, a move that aligns more with how Tesla approaches full-self driving. We see more room for upside from these levels.

Duolingo (DUOL): +15%

Duolingo shares surged higher this week, hitting new all-time highs. Many investors lost faith in the company after GPT demoed its language learnings skills but we rightfully held. This app is sticky and social and app usage metrics show acceleration, up +52% YoY in August, also at all-time highs.

Shopify (SHOP): +8%

Shares of Shopify popped higher this week after Redburn Atlantic upgraded its rating to 'buy,' driven by the company's strong position in the rapidly expanding social e-commerce market. Analysts cited growth catatlysts including Shopify's deep integrations with major social platforms like TikTok and Instagram, which position it to capture a significant share of the $350 billion social e-commerce market by 2028. We remain bullish.

Exact Sciences (EXAS): +8%

Exact Sciences released data showing its blood-based colorectal cancer test demonstrated 88.3% sensitivity for cancer detection and 31.2% for advanced precancerous lesions, with a 90.1% specificity rate. The results bring the test closer to offering a non-invasive screening alternative, as the company aims to compete with Guardant Health’s FDA-approved Shield test. Exact plans to submit the test for FDA approval following additional studies, with pivotal BLUE-C study results expected in the first half of 2025.

Read the rest of our weekly summary here, including a look into what's new with Snapchat (SNAP).

This section is restricted to LikeFolio Pro Members only.